Company intelligence / Profile preview

Paleo

Ownership: Private
Development stage: Commercial

Overview

Paleo has developed a precision fermentation platform that produces bio-identical myoglobin for use as an ingredient in plant-based meat and fish alternatives. Their product enables authentic meat flavor and nutrition without using animals. The company is scaling up production and targeting commercial partnerships with plant-based food manufacturers[1][2][3].

Modalities: Recombinant proteinPrecision fermentation-based protein production
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Paleo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paleo.

Explore the full profile